The final rule and other mechanisms to reduce the backlog of Medicare appeals. Will they work?
In recent years, the Medicare appeals process has experienced an unprecedented and sustained increase in the number of appeals. A variety of factors have contributed to this and to the resulting backlog of cases. In this issue of the Health Care Lawyer, attorney Michelle E. Lin examines and explains new regulations designed to improve the appeals process making it more efficient and consistent.
Prescription opioids—Medicare needs to expand oversight efforts to reduce the risk of harm
The over-prescription and misuse of highly addictive opioid pain medications has become a matter of intense national concern. In 2016, Medicare spending for opioids was almost $4.1 billion. In November, the Government Accountability Office (GAO) released a report examining Medicare’s oversight with respect to opioid use and prescription. A summary of this report is presented in this issue.